Who this is for
This page is for people with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer who are making decisions about their next line of treatment, particularly after progression on CDK4/6 inhibitors.
If chemotherapy has been recommended and you are unsure whether it is the right next step, this article explains when a second opinion may be helpful.
When is the ideal time to seek a second opinion?
There is no single “correct” moment.
However, a second opinion is often most useful:
• When your cancer has progressed after a major line of therapy
• Before starting a new treatment with significant side effects
• When genomic or mutation testing has not yet been discussed
• When multiple treatment options may exist
• When you feel uncertain or rushed in decision-making
Seeking a second opinion does not mean you distrust your oncologist.
It means you want to feel confident in the plan.
If chemotherapy has been recommended
Chemotherapy is an effective and important treatment in advanced breast cancer. In some situations — particularly when disease is progressing quickly or symptoms are significant — it is clearly the right next step.
However, in hormone receptor–positive, HER2-negative disease, there are circumstances where further targeted therapies may still be appropriate before chemotherapy is started.
The decision depends on:
• Prior response duration
• Mutation testing results (PIK3CA, ESR1 and others)
• Pace and location of disease
• Overall health
• Patient preference
If these factors have not been fully reviewed, it is reasonable to pause briefly and clarify options before beginning treatment.
A short delay to ensure the right sequencing rarely changes outcomes — but clarity often reduces anxiety.
What a second opinion should provide
A useful second opinion should not simply repeat the same information.
It should:
• Review prior treatments and imaging carefully
• Confirm whether mutation testing has been completed
• Consider PBS-listed and clinical trial options in Australia
• Clarify whether chemotherapy is urgent or elective
• Provide a clear written recommendation
In Melbourne and across Australia, most oncologists support thoughtful second opinions. Collaborative care is common, and it is entirely appropriate to return to your primary oncologist afterward.
Is it too late once chemotherapy has started?
No.
Even if chemotherapy has begun, treatment strategy can still be reviewed. Decisions in advanced breast cancer are dynamic, and reassessment is part of routine care.
The key is that decisions feel informed — not reactive.
International patients, including Sri Lanka
Patients from Sri Lanka and other countries sometimes seek an Australian second opinion when chemotherapy has been proposed after CDK4/6 progression.
In these situations, reviewing mutation testing, treatment history and access to targeted therapies within the Australian system can help clarify whether sequencing alternatives exist.
Key Takeaway
A second opinion is most helpful at major treatment decision points.
Chemotherapy may be appropriate — but targeted options should be reviewed when relevant.
The goal is not delay, but confidence in the treatment plan.